Showing results (141-150 of 185) with videos related to
Sort By:
Pageof 19
Japanese Journal of Clinical Oncology|January 6, 2007
Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma: Kitasato Gynecologic Radiation Oncology Group (KGROG 0501)Yuzuru Niibe, Kazushige Hayakawa, Shinpei Tsunoda, et al.Pharmaceutics|March 26, 2022
Clinical Practice Guidelines for Therapeutic Drug Monitoring of Vancomycin in the Framework of Model-Informed Precision Dosing: A Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug MonitoringKazuaki Matsumoto, Kazutaka Oda, Kensuke Shoji, et al.Journal of Neurology|February 24, 2021
Phenotypic and molecular diversities of spinocerebellar ataxia type 2 in JapanRino Inada, Makito Hirano, Nobuyuki Oka, et al.Journal of Global Antimicrobial Resistance|August 9, 2021
Candidates for area under the concentration-time curve (AUC)-guided dosing and risk reduction based on analyses of risk factors associated with nephrotoxicity in vancomycin-treated patientsNaoto Hashimoto, Toshimi Kimura, Yukihiro Hamada, et al.Frontiers in Oncology|February 16, 2023
Development of a population pharmacokinetics and pharmacodynamics model of glucarpidase rescue treatment after high-dose methotrexate therapyYutaka Fukaya, Toshimi Kimura, Yukihiro Hamada, et al.Molecular Imaging and Biology|July 24, 2019
Initial Evaluation of AF78: a Rationally Designed Fluorine-18-Labelled PET Radiotracer Targeting Norepinephrine TransporterXinyu Chen, Alexander Fritz, Rudolf A Werner, et al.International Journal of Nanomedicine|June 6, 2017
Aggregation is a critical cause of poor transfer into the brain tissue of intravenously administered cationic PAMAM dendrimer nanoparticlesYoshika Kurokawa, Hideko Sone, Tin-Tin Win-Shwe, et al.EJNMMI Radiopharmacy and Chemistry|July 6, 2025
Development of a CYP11B2 imaging tracer for primary aldosteronism: basic evaluation of iodine- and fluorine-incorporated pyridinyldihydroquinolinone derivativesYusuke Yagi, Hiroyuki Kimura, Riko Fuseda, et al.European Journal of Nuclear Medicine and Molecular Imaging|February 11, 2025
Theranostics using 89Zr/177Lu-labeled antibody targeting erythropoietin-producing hepatocellular A2 (EphA2)Tadashi Watabe, Takumi Iwasawa, Hiroyuki Kimura, et al.Proceedings of the National Academy of Sciences of the United States of America|September 26, 2018
l-Serine-modified polyamidoamine dendrimer as a highly potent renal targeting drug carrierSatoru Matsuura, Hidemasa Katsumi, Hiroe Suzuki, et al.Pageof 19